TAILORx trial finds 99 percent of women with low Oncotype DX® Recurrence Score® are free of breast cancer recurrence after five years of hormone therapy alone

… exceeded recurrences of the original breast cancer, resulting in 93.8 percent … risk-stratify patients with early stage breast cancer, and indicate that the findings … give women with early stage breast cancer greater certainty that anti-estrogen therapy …